Respiratory syncytial virus infection in adults

Edward E Walsh1

  • 1Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14621, USA. edward.walsh@rochestergeneral.org

Insights

Respiratory syncytial virus (RSV) causes significant illness in infants and adults. Current treatments are limited, highlighting the urgent need for an effective RSV vaccine.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in infants, leading to significant hospitalizations and deaths.
  • RSV also causes substantial disease in adult populations, including the elderly, immunocompromised, and those with chronic conditions, though diagnosis is challenging due to low viral shedding.

Purpose of the Study:

  • To review the impact of RSV in both pediatric and adult populations.
  • To discuss the limitations of current diagnostic methods and antiviral therapies for RSV.
  • To highlight the potential of immunization as the most promising strategy for reducing RSV burden.

Main Methods:

  • Literature review of RSV epidemiology, clinical manifestations, diagnosis, and treatment.
  • Analysis of current therapeutic and prophylactic options, including their limitations in adults.
  • Evaluation of immunization strategies for RSV prevention.

Main Results:

  • RSV is a leading cause of pediatric respiratory illness but also affects all adult age groups, causing significant morbidity and mortality.
  • Molecular tests are optimal for diagnosing RSV in adults, but antiviral therapies like ribavirin and palivizumab have limited efficacy and are primarily used in infants.
  • Currently, no effective RSV vaccine is available, representing a critical unmet medical need.

Conclusions:

  • RSV poses a significant health threat across all age groups, necessitating improved diagnostic and therapeutic approaches.
  • Effective immunization strategies hold the greatest promise for controlling RSV infections and reducing disease burden in the adult population.
  • Further research and development are crucial for creating an effective RSV vaccine and improving management of RSV infections.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...